Medtronic plc announced it is seeking an expedited regulatory pathway for a technology.

The entities involved

• Medtronic plc →

  medical device company

  • Wolfe Research upgraded Medtronic's stock rating on July 4, 2025, coinciding with the company announcing the integration of the Affera platform.Sun 14:50
  • MarketBeat listed Danaher, Dexcom, Medtronic, Gilead Sciences, and Boston Scientific as stocks to watch on September 22, 2026.Tue 20:16
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Galway →

  city in Ireland

  • Various political parties, including Independent Ireland, Fine Gael, and Labour Party, participated in constituency races in Galway West and Dublin Central.Sat 13:03
  • Fianna Fáil candidate Patrick Kielty campaigned in Galway West, visiting Dunnes Stores and discussing deep fakes.Sat 13:03

Related events

• AOTI Inc.'s therapy received regulatory clearance from the FDA, with the company based in Galway and Oceanside.Jun 19
• Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.Sep 22
• BioPorto is seeking regulatory pathways and activating its first clinical site in collaboration with Massachusetts General Hospital.Aug 18
• The FDA and Intellia Therapeutics are preparing a regulatory filing for product approval.Jun 24
• FDA approval is the goal for product candidates from Daré Bioscience, Inc.Jun 7